Global Circulating Tumor Cells Competitive Landscape Professional Research Report 2024

Research Summary

Circulating Tumor Cells (CTCs) are rare cancer cells that have detached from a solid tumor and entered the bloodstream, allowing them to circulate throughout the body. These cells play a significant role in cancer metastasis, as they can potentially seed new tumors in distant organs. CTCs can be isolated from a patient's blood sample and analyzed to provide valuable information about the cancer's progression, prognosis, and response to treatment. Detecting and analyzing CTCs is a non-invasive method that can help oncologists monitor disease progression and treatment effectiveness, and it may also guide treatment decisions for personalized therapies. While CTCs are a promising avenue for cancer research and personalized medicine, their rarity and heterogeneity pose challenges in their isolation and analysis. Nonetheless, ongoing advancements in technology and research are making CTC analysis increasingly important in cancer diagnosis and management.

According to DIResearch's in-depth investigation and research, the global Circulating Tumor Cells market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Circulating Tumor Cells include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, Guangzhou Wondfo Biotech, CytoTrack, Celsee, ANGLE plc, Clearbridge Biomedics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Circulating Tumor Cells. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Circulating Tumor Cells market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Circulating Tumor Cells market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Circulating Tumor Cells industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Circulating Tumor Cells Include:

Menarini-Silicon Biosystems

Qiagen (Adnagen)

Advanced Cell Diagnostics

ApoCell

Epic Sciences

Greiner Bio-one GmbH

Cynvenio

SurExamBio-Tech

Fluxion Biosciences

Ikonisys

Hangzhou Watson Biotech

Biocept

Guangzhou Wondfo Biotech

CytoTrack

Celsee

ANGLE plc

Clearbridge Biomedics

Circulating Tumor Cells Product Segment Include:

CTC Enrichment

CTC Detection

CTC Analysis

Circulating Tumor Cells Product Application Include:

Breast Cancer

Prostate Cancer

Colorectal Cancer

Lung Cancer

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Circulating Tumor Cells Industry PESTEL Analysis

Chapter 3: Global Circulating Tumor Cells Industry Porter's Five Forces Analysis

Chapter 4: Global Circulating Tumor Cells Major Regional Market Size and Forecast Analysis

Chapter 5: Global Circulating Tumor Cells Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Circulating Tumor Cells Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Circulating Tumor Cells Market Overview

1.1 Product Definition and Statistical Scope

1.2 Circulating Tumor Cells Product by Type

1.2.1 Global Circulating Tumor Cells Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 CTC Enrichment

1.2.3 CTC Detection

1.2.4 CTC Analysis

1.3 Circulating Tumor Cells Product by Application

1.3.1 Global Circulating Tumor Cells Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Colorectal Cancer

1.3.5 Lung Cancer

1.3.6 Others

1.4 Global Circulating Tumor Cells Market Revenue Analysis (2019-2030)

1.5 Circulating Tumor Cells Market Development Status and Trends

1.5.1 Circulating Tumor Cells Industry Development Status Analysis

1.5.2 Circulating Tumor Cells Industry Development Trends Analysis

2 Circulating Tumor Cells Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Circulating Tumor Cells Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Circulating Tumor Cells Market Analysis by Regions

4.1 Circulating Tumor Cells Overall Market: 2023 VS 2024 VS 2030

4.2 Global Circulating Tumor Cells Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Circulating Tumor Cells Revenue and Market Share by Region (2019-2024)

4.2.2 Global Circulating Tumor Cells Revenue Forecast by Region (2025-2030)

5 Global Circulating Tumor Cells Market Size by Type and Application

5.1 Global Circulating Tumor Cells Market Size by Type

5.2 Global Circulating Tumor Cells Market Size by Application

6 North America

6.1 North America Circulating Tumor Cells Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Circulating Tumor Cells Market Size by Type

6.4 North America Circulating Tumor Cells Market Size by Application

6.5 North America Circulating Tumor Cells Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Circulating Tumor Cells Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Circulating Tumor Cells Market Size by Type

7.4 Europe Circulating Tumor Cells Market Size by Application

7.5 Europe Circulating Tumor Cells Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Circulating Tumor Cells Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Circulating Tumor Cells Market Size by Type

8.4 China Circulating Tumor Cells Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Circulating Tumor Cells Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Circulating Tumor Cells Market Size by Type

9.4 APAC (excl. China) Circulating Tumor Cells Market Size by Application

9.5 APAC (excl. China) Circulating Tumor Cells Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Circulating Tumor Cells Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Circulating Tumor Cells Market Size by Type

10.4 Latin America Circulating Tumor Cells Market Size by Application

10.5 Latin America Circulating Tumor Cells Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Circulating Tumor Cells Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Circulating Tumor Cells Market Size by Type

11.4 Middle East & Africa Circulating Tumor Cells Market Size by Application

11.5 Middle East & Africa Circulating Tumor Cells Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Circulating Tumor Cells Market Revenue by Key Manufacturers (2020-2024)

12.2 Circulating Tumor Cells Competitive Landscape Analysis and Market Dynamic

12.2.1 Circulating Tumor Cells Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Menarini-Silicon Biosystems

13.1.1 Menarini-Silicon Biosystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells Product Portfolio

13.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Qiagen (Adnagen)

13.2.1 Qiagen (Adnagen) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Qiagen (Adnagen) Circulating Tumor Cells Product Portfolio

13.2.3 Qiagen (Adnagen) Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Advanced Cell Diagnostics

13.3.1 Advanced Cell Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Advanced Cell Diagnostics Circulating Tumor Cells Product Portfolio

13.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 ApoCell

13.4.1 ApoCell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 ApoCell Circulating Tumor Cells Product Portfolio

13.4.3 ApoCell Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Epic Sciences

13.5.1 Epic Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Epic Sciences Circulating Tumor Cells Product Portfolio

13.5.3 Epic Sciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Greiner Bio-one GmbH

13.6.1 Greiner Bio-one GmbH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Greiner Bio-one GmbH Circulating Tumor Cells Product Portfolio

13.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Cynvenio

13.7.1 Cynvenio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Cynvenio Circulating Tumor Cells Product Portfolio

13.7.3 Cynvenio Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 SurExamBio-Tech

13.8.1 SurExamBio-Tech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 SurExamBio-Tech Circulating Tumor Cells Product Portfolio

13.8.3 SurExamBio-Tech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Fluxion Biosciences

13.9.1 Fluxion Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Fluxion Biosciences Circulating Tumor Cells Product Portfolio

13.9.3 Fluxion Biosciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Ikonisys

13.10.1 Ikonisys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Ikonisys Circulating Tumor Cells Product Portfolio

13.10.3 Ikonisys Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Hangzhou Watson Biotech

13.11.1 Hangzhou Watson Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Hangzhou Watson Biotech Circulating Tumor Cells Product Portfolio

13.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Biocept

13.12.1 Biocept Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Biocept Circulating Tumor Cells Product Portfolio

13.12.3 Biocept Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Guangzhou Wondfo Biotech

13.13.1 Guangzhou Wondfo Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Guangzhou Wondfo Biotech Circulating Tumor Cells Product Portfolio

13.13.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 CytoTrack

13.14.1 CytoTrack Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 CytoTrack Circulating Tumor Cells Product Portfolio

13.14.3 CytoTrack Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Celsee

13.15.1 Celsee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Celsee Circulating Tumor Cells Product Portfolio

13.15.3 Celsee Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 ANGLE plc

13.16.1 ANGLE plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 ANGLE plc Circulating Tumor Cells Product Portfolio

13.16.3 ANGLE plc Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Clearbridge Biomedics

13.17.1 Clearbridge Biomedics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Clearbridge Biomedics Circulating Tumor Cells Product Portfolio

13.17.3 Clearbridge Biomedics Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Circulating Tumor Cells Industry Chain Analysis

14.2 Circulating Tumor Cells Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Circulating Tumor Cells Typical Downstream Customers

14.4 Circulating Tumor Cells Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support